Metro Healthcare BhdXKLS:0329 57 Buyback Yield % is 0.00 as of Jul. 12, 2026. GuruFocus rates XKLS:0329 with a GF Score™ of 57/100 and a GF Value™ of RM0.31 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 274 Healthcare Providers & Services companies, Metro Healthcare Bhd ranks worse than 364963.14% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
Metro Healthcare Bhd Buyback Yield % Related Terms
Metro Healthcare Bhd Buyback Yield % Historical Data
* Premium members only.
The historical data trend for Metro Healthcare Bhd's Buyback Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKLS:0329 vs HCA, THC, DVA: Buyback Yield % Comparison
For the Medical Care Facilities subindustry, Metro Healthcare Bhd's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Metro Healthcare Bhd Buyback Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Metro Healthcare Bhd's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Metro Healthcare Bhd's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Metro Healthcare Bhd (XKLS:0329) has a Buyback Yield % of 0.00 as of Jul. 12, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Metro Healthcare Bhd and its competitors. According to the industry distribution chart, Metro Healthcare Bhd ranks #999999 out of 274 companies in the Healthcare Providers & Services industry.
Is Metro Healthcare Bhd's Buyback Yield % too high?
Metro Healthcare Bhd's current Buyback Yield % is 0.00. Based on the distribution chart, Metro Healthcare Bhd ranks #999999 out of 274 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Metro Healthcare Bhd has a GF Score™ of 57/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Metro Healthcare Bhd's Buyback Yield % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Metro Healthcare Bhd ranks #999999 out of 274 companies for Buyback Yield %. This places Metro Healthcare Bhd in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Healthcare Providers & Services company?
A good Buyback Yield % depends on the Healthcare Providers & Services industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Metro Healthcare Bhd and its competitors. Metro Healthcare Bhd's current Buyback Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Metro Healthcare Bhd stock overvalued right now?
Based on GuruFocus' analysis, Metro Healthcare Bhd (XKLS:0329) is currently considered Modestly Undervalued. The stock's GF Value™ is RM0.31, compared to a current price of RM0.24 — trading 24.2% below its estimated fair value. The current Buyback Yield % is 0.00. Metro Healthcare Bhd's overall GF Score™ is 57/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Metro Healthcare Bhd (XKLS:0329), the current Buyback Yield % is 0.00 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Metro Healthcare Bhd (XKLS:0329) Overvalued in 2026?
Based on GuruFocus' analysis, Metro Healthcare Bhd stock appears to be undervalued.
The current stock price of RM0.24 is trading 24.2% below its estimated GF Value™ of RM0.31.
GuruFocus considers Metro Healthcare Bhd to be Modestly Undervalued.
Key valuation signals for XKLS:0329:
Buyback Yield %: 0.00
GF Value™: RM0.31 vs. price of RM0.24 (24.2% below fair value)
No single metric tells the full story. See the XKLS:0329 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Metro Healthcare Bhd is engaged in the provision of women healthcare services. The company offers various services such as obstetrics, gynecology impatient services, and diagnostic medical imaging services. It also provides semen analysis, intracytoplasmic sperm injection, blastocyst culture, assisted hatching, frozen embryo transfer, preimplantation genetic screening, and infertility consultation services. The company serves patients in Malaysia. The firm's business segment includes O&G healthcare services, Complementary services, and Hospital services.
57GF Score
Get the complete analysis for XKLS:0329
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:0329 has been successfully added to your 
